230 related articles for article (PubMed ID: 7867196)
1. Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model.
Montoney M; Gardell SJ; Marder VJ
Circulation; 1995 Mar; 91(5):1540-4. PubMed ID: 7867196
[TBL] [Abstract][Full Text] [Related]
2. Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time model.
Mellott MJ; Ramjit DR; Stabilito II; Hare TR; Senderak ET; Lynch JJ; Gardell SJ
Thromb Haemost; 1995 Mar; 73(3):478-83. PubMed ID: 7545321
[TBL] [Abstract][Full Text] [Related]
3. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.
Weitz JI
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):19S-23S. PubMed ID: 8770837
[TBL] [Abstract][Full Text] [Related]
4. An animal model of fibrinolytic bleeding based on the rebleed phenomenon: application to a study of vulnerability of hemostatic plugs of different age.
Marder VJ; Shortell CK; Fitzpatrick PG; Kim C; Oxley D
Thromb Res; 1992 Jul; 67(1):31-40. PubMed ID: 1440514
[TBL] [Abstract][Full Text] [Related]
5. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ
Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443
[TBL] [Abstract][Full Text] [Related]
6. Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis.
Mellott MJ; Stabilito II; Holahan MA; Cuca GC; Wang S; Li P; Barrett JS; Lynch JJ; Gardell SJ
Arterioscler Thromb; 1992 Feb; 12(2):212-21. PubMed ID: 1371932
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
8. Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits.
Gardell SJ; Ramjit DR; Stabilito II; Fujita T; Lynch JJ; Cuca GC; Jain D; Wang SP; Tung JS; Mark GE
Circulation; 1991 Jul; 84(1):244-53. PubMed ID: 1905593
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
Kruithof EK; Schleuning WD
Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
[TBL] [Abstract][Full Text] [Related]
10. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Hare TR; Gardell SJ
Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
[TBL] [Abstract][Full Text] [Related]
11. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
12. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
[TBL] [Abstract][Full Text] [Related]
13. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.
Benedict CR; Refino CJ; Keyt BA; Pakala R; Paoni NF; Thomas GR; Bennett WF
Circulation; 1995 Nov; 92(10):3032-40. PubMed ID: 7586274
[TBL] [Abstract][Full Text] [Related]
14. A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase.
Wikström K; Mattsson C; Pohl G
Thromb Res; 1993 May; 70(3):217-24. PubMed ID: 8392227
[TBL] [Abstract][Full Text] [Related]
15. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models.
Vanderschueren S; Collen D
Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729
[TBL] [Abstract][Full Text] [Related]
18. Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.
Vaughan DE; Declerck PJ; De Mol M; Collen D
J Clin Invest; 1989 Aug; 84(2):586-91. PubMed ID: 2503540
[TBL] [Abstract][Full Text] [Related]
19. Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator.
Gardell SJ; Hare TR; Bergum PW; Cuca GC; O'Neill-Palladino L; Zavodny SM
Blood; 1990 Dec; 76(12):2560-4. PubMed ID: 2124935
[TBL] [Abstract][Full Text] [Related]
20. Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.
Kazemali M; Majidzadeh-A K; Sardari S; Saadatirad AH; Khalaj V; Zarei N; Barkhordari F; Adeli A; Mahboudi F
Enzyme Microb Technol; 2014 Dec; 67():82-6. PubMed ID: 25442953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
